Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Tumori|January 14, 2017
Surgery of locally advanced and metastatic kidney cancer after tyrosine kinase inhibitors therapy: single institute experienceAlberto De Gobbi, Davide Biasoni, Mario Catanzaro, et al.
International Journal of Cancer|January 30, 2024
SAA1-dependent reprogramming of adipocytes by tumor cells is associated with triple negative breast cancer aggressivenessIlona Rybinska, Nunzia Mangano, Sandra L Romero-Cordoba, et al.
Oncotarget|September 4, 2015
Whole-transcriptome analysis links trastuzumab sensitivity of breast tumors to both HER2 dependence and immune cell infiltrationTiziana Triulzi, Loris De Cecco, Marco Sandri, et al.
The Journal of Urology|April 30, 2013
Persistent CD30 expression by embryonal carcinoma in the treatment time course: prognostic significance of a worthwhile target for personalized treatmentPatrizia Giannatempo, Biagio Paolini, Rosalba Miceli, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 10, 2021
Uterine serous carcinoma: role of surgery, risk factors and oncologic outcomes. Experience of a tertiary centerAntonino Ditto, Umberto Leone Roberti Maggiore, Salvatore Lopez, et al.
Tumori|August 14, 2023
Periprosthetic effusions surrounding breast expander: a flow cytometric, immunohistochemical and molecular characterizationLaura Sala, Chiara Maura Ciniselli, Fabio Bozzi, et al.
Scientific Reports|February 9, 2024
Immunological characterization of a long-lasting response in a patient with metastatic triple-negative breast cancer treated with PD-1 and LAG-3 blockadeLicia Rivoltini, Chiara Camisaschi, Giovanni Fucà, et al.
Molecular Oncology|February 1, 2021
A combination of extracellular matrix- and interferon-associated signatures identifies high-grade breast cancers with poor prognosisMara Lecchi, Paolo Verderio, Vera Cappelletti, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 20, 2023
Characteristics and outcomes of surgically staged multiple classifier endometrial cancerGiorgio Bogani, Ilaria Betella, Francesco Multinu, et al.
Scientific Reports|January 31, 2024
A gene expression-based classifier for HER2-low breast cancerSerena Di Cosimo, Sara Pizzamiglio, Chiara Maura Ciniselli, et al.
Pageof 9